证券代码：601319 证券简称：中国人保 公告编号：临 2024-032 中国人民保险集团股份有限公司 原保险保费收入公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 中国人民保险集团股份有限公司（"本公司"）2024 年 1 月 1 日至 2024 年 8 月 31 日经由本公司子公司中国人民财产保险股份有限 公司、中国人民人寿保险股份有限公司及中国人民健康保险股份有限 公司所获得的原保险保费收入分别为人民币 382,151 百万元、人民币 92,281 百万元及人民币 41,246 百万元。 中国人民财产保险股份有限公司上述期间原保险保费收入分类 明细如下： | | 单位：人民币百万元，百分比除外 | | | --- | --- | --- | | | 2024年1-8月 | 同比（%） | | 机动车辆险 | 186,469 | 3.0 | | 意外伤害及健康险 | 83,861 | 7.2 | | 农险 | 50,308 | 1.7 | | 责任险 | 26,855 | 12.6 | | 企业财产险 | 12, ...

中国人民保险集团股份有限公司 投资者关系活动记录表 1 | 7、 未来公司权益投资的策略？是否会减少基金投 | | --- | | 资，更多的去自己投资高股息股票？ | | 8、 今年年初的业绩发布会上，管理层提出要通过 | | 加快发展优质业务等举措提升非车险盈利能力。目前来 | | 看，整体成效如何？哪些非车险业务是需要进一步调整 | | 的？如何调整？ | | 9、 中国人保制定了服务中国式现代化的八项战略 | | 服务，我今年去了杭州、嘉兴、青岛等多个地方调研，发 | | 现各地人保都有一些很有意思的保险产品创新，既落实 | | 了八项战略服务，又填补了很多领域的保险保障空白。想 | | 请管理层整体介绍一下公司落实这八项战略服务的机制 | | 建设，尤其是如何鼓励保险产品创新的？ | | 10、 上半年人保寿险新单业务和整体业务的负债成 | | 本分别是多少？应对利差损的产品策略是怎样的？ | | 11、 今年以来，人保保费增速有一定的放缓，主要 | | 原因是什么？公司对未来三到五年保费增速的判断？ | | 12、 对于中期股息，集团和财险未来派发的主要政 | | 策和标准是什么？集团和财险全年分 ...

二、非執行董事 王清劍 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 1339 董事名單與其角色和職能 一、執行董事 趙 鵬 （副董事長） 李祝用 肖建友 邵善波 高永文 崔 歷 徐麗娜 王鵬程 四、董事會專業委員會 董事會下設五個董事會專業委員會，各董事會專業委員會的組成如下： | 委員會 | | | | | | 風險管理與 | | --- | --- | --- | --- | --- | --- | --- | | | | | 提名薪酬 | 戰略與投資 | 關聯交易 | 消費者權益 | | 董 | 事 | 審計委員會 | 委員會 | 委員會 | 控制委員會 | 保護委員會 | | 趙 | 鵬 | | | | | | | 李祝用 | | | | | | | | 肖建友 | | | | | | | | 王清劍 | | | | | | | | 苗福生 | | | | | | | | 王少群 | | | | | | | | 喻 | 強 | | | | ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 中国人民保险集团股份有限公司 关于董事长辞任的公告 证券代码：601319 证券简称：中国人保 公告编号：临 2024-031 中国人民保险集团股份有限公司（"本公司"）董事会收到王廷 科先生的辞呈。王廷科先生因工作需要，辞去本公司执行董事、董事 长及董事会战略与投资委员会主任委员等职务。该辞任自 2024 年 9 月 5 日起生效。王廷科先生已确认其与本公司董事会无不同意见，亦 没有任何其他事项需要通知本公司股东。 中国人民保险集团股份有限公司董事会 2024 年 9 月 6 日 王廷科先生在任职期间恪尽职守，勤勉履职，求真务实，守正创 新，为集团改革发展做了大量卓有成效的工作。本公司董事会向王廷 科先生对本公司做出的重要贡献表示衷心感谢！ 特此公告。 王廷科先生在担任本公司董事长期间，团结带领集团干部员工， 坚持以习近平新时代中国特色社会主义思想为指导，坚持金融工作政 治性、人民性，扎实做好金融"五篇大文章"，务实推进卓越战略优 化，深入实施八项战略服务，坚守风险防控底线， ...

Investment Rating - The investment rating for the company is "Outperform the Market" and is maintained [2][7]. Core Views - The report highlights a significant increase in net profit and new business value (NBV) for the first half of 2024, with net profit reaching 22.7 billion yuan, up 14.1% year-on-year, and a quarterly profit of 13.7 billion yuan, up 68.2% year-on-year [6][7]. - The report emphasizes the company's competitive advantage in the property insurance sector, particularly in the auto insurance business, which is expected to enhance profitability compared to smaller competitors [7][9]. Summary by Sections Financial Performance - The company reported a net profit of 22.7 billion yuan for the first half of 2024, with a year-on-year increase of 14.1%. The return on equity (ROE) was 9.0%, up 0.7 percentage points year-on-year [6]. - The total assets increased by 6.9% to 1.53 trillion yuan, with fixed income and equity assets accounting for 67.3% and 19.2% respectively [7]. - The annualized total investment yield was 4.1%, down 0.8 percentage points year-on-year, while the net investment yield was 3.8%, down 0.6 percentage points year-on-year [7]. Insurance Segment Performance - In the property insurance segment, premium income grew steadily, with a year-on-year increase of 3.7%, and a market share of 34.0%, up 1.5 percentage points from the beginning of the year [6][7]. - The comprehensive cost ratio for property insurance was 96.8%, up 0.4 percentage points year-on-year, with a claims ratio of 70.7%, up 1.2 percentage points [6][16]. - In the life insurance segment, net profit reached 9.9 billion yuan, a significant increase of 191% year-on-year, with NBV growing by 91% [6][7]. Valuation - The report provides a valuation range for the company between 6.56 and 7.12 yuan per share, based on a segmented valuation approach [9][22]. - The estimated price-to-earnings (P/E) ratio for 2024 is projected at 9.69, while the price-to-book (P/B) ratio is expected to be 0.99 [22][21]. Market Comparison - The company's stock price closed at 6.00 yuan, with a 52-week price fluctuation between 4.52 and 6.14 yuan [2][8]. - The report indicates that the company's performance has outpaced the Shanghai and Shenzhen 300 index, with relative increases of 12.0% over one month and 20.0% over two months [4].

Investment Rating - The report maintains a "Recommended" rating for the company with a target price of 7.3 CNY, compared to the current price of 5.75 CNY [2][8]. Core Views - The company achieved a significant growth in New Business Value (NBV), with a year-on-year increase of 115.6% to 6.96 billion CNY in the first half of 2024. The net profit also showed a strong growth of 14.1% year-on-year, reaching 22.69 billion CNY [2][8]. - The report highlights the company's leading position in the property insurance sector, with a market share of one-third, and emphasizes the continuous improvement in risk management driving underwriting profitability [2][8]. - The report anticipates that the company's life insurance new business will face reduced pressure in the second half of 2024, supported by a further decrease in the preset interest rate, which will enhance the new business value rate [2][8]. Summary by Sections Financial Performance - In H1 2024, the company reported insurance service revenue of 261.63 billion CNY, a year-on-year increase of 6.0%. The return on equity (ROE) was 9.0%, up by 0.7 percentage points [2][8]. - The property insurance segment generated 235.84 billion CNY in revenue, with a combined ratio (COR) of 96.8%, reflecting a slight increase due to natural disaster impacts [2][8]. - The life insurance segment's NBV grew by 91.0% to 3.94 billion CNY, driven by improvements in new business value rates [2][8]. Investment Strategy - The company has adjusted its investment strategy by reducing holdings in TPL funds and increasing investments in OCI stocks to stabilize financial statements. As of H1 2024, the total investment asset scale increased by 6.9% to 1,531.83 billion CNY [2][8]. - The net and total investment yield rates were 3.8% and 4.1%, respectively, both showing a decline compared to the previous year [2][8]. Future Outlook - The report projects an increase in earnings per share (EPS) for 2024-2026, with estimates of 0.71 CNY, 0.81 CNY, and 0.89 CNY respectively, reflecting an optimistic outlook for the company's performance [2][8]. - The company is expected to continue benefiting from the growing demand for healthcare and elderly care services, which will likely lead to strong performance in the health insurance sector [2][8].

Investment Rating - The report maintains a "Buy" rating for China People's Insurance Group with a target price of HKD 3.94 per share, corresponding to a P/B ratio of 0.66 for 2024 [5]. Core Views - The company's net profit attributable to shareholders for the first half of 2024 increased by 14.1% year-on-year to RMB 22.687 billion, primarily driven by improved underwriting profits, while the decline in investment profits narrowed significantly [4][5]. - The report highlights a robust growth in property insurance premiums, with a year-on-year increase of 3.7% to RMB 311.996 billion in H1 2024, and a notable improvement in underwriting profitability in Q2 compared to Q1 [5]. - The life insurance new business value (NBV) exceeded expectations, showing a year-on-year growth of 91.0% in H1 2024, driven by significant improvements in new business value rates [5]. Summary by Sections Financial Performance - The total investment income for H1 2024 was RMB 29.064 billion, reflecting a year-on-year decline of 7.7% [5]. - The company declared an interim dividend of RMB 0.063 per share, indicating an increase in dividend frequency [5]. Property Insurance - The combined ratio (COR) for H1 2024 was 96.2%, a slight increase of 0.4 percentage points year-on-year, but showed significant improvement in Q2 with a COR of 94.7% [5]. - The loss ratio increased by 1.2 percentage points to 70.1%, while the expense ratio improved by 0.8 percentage points to 26.1% [5]. Life Insurance - The NBV for life insurance in H1 2024 was significantly boosted by a 5.5 percentage point improvement in new business value rates, reaching 11.3% [5]. - The contribution from individual insurance and bancassurance NBV grew by 45.5% and 44.7% respectively [5]. Market Outlook - Catalysts for future performance include better-than-expected natural disaster outcomes in the second half and a recovery in capital markets [5].

Investment Rating - The investment rating for China People's Insurance Group is "Buy" (maintained) [5] Core Views - The company reported a 6.0% year-on-year increase in insurance service revenue to CNY 261.63 billion for H1 2024, with a net profit attributable to shareholders of CNY 23.40 billion, up 13.7% year-on-year [2][7] - The combined ratio (COR) for property insurance was 96.2%, an increase of 0.4 percentage points year-on-year, indicating a stable underwriting profitability [7] - The new business value (NBV) for life insurance reached CNY 3.94 billion, a significant increase of 91.0% year-on-year, while health insurance NBV surged by 159.0% to CNY 3.03 billion [7] Financial Performance - For H1 2024, the property insurance segment achieved original insurance premium income of CNY 311.996 billion, a 3.7% increase year-on-year, slightly below the industry average of 4.5% [7] - The COR for property insurance improved, with a claims ratio of 70.1% and an expense ratio of 26.1%, reflecting a year-on-year increase of 1.2 percentage points and a decrease of 0.8 percentage points, respectively [7] - The life insurance segment's net profit was CNY 9.93 billion, up 191.1% year-on-year, driven by improved investment returns and reduced liability costs [7] Profit Forecast - The company is expected to achieve net profits of CNY 28.4 billion, CNY 31.3 billion, and CNY 36.4 billion for the years 2024, 2025, and 2026, respectively, with growth rates of 27%, 10%, and 16% [7][8]

证券代码：601319 证券简称： 中国人保 公告编号：临 2024-028 中国人民保险集团股份有限公司 第五届董事会第二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完 整性承担法律责任。 本公司第五届董事会第二次会议（以下简称"会议"）的通知和 材料于 2024 年 8 月 8 日以书面方式通知全体董事，会议于 2024 年 8 月 28 日在北京市西城区西长安街 88 号中国人保大厦以现场会议方 式召开。会议应出席董事 14 名，现场出席 10 名，视频连线出席 3 名， 委托出席 1 名。独立董事高永文、崔历、徐丽娜以视频连线方式出席 会议，王廷科董事长委托赵鹏副董事长主持会议并代为行使表决权。 监事会成员及部分高级管理层成员列席了会议。会议的召开符合《中 华人民共和国公司法》等相关法律、行政法规、部门规章和《中国人 民保险集团股份有限公司章程》的规定，会议合法、有效。 经与会董事审议并表决，形成以下会议决议： 表决结果：14 票同意，0 票反对，0 票弃权 一、审议通过了《关于2024年A股和H股半年度定期报告的议 案 ...

证券代码：601319 证券简称：中国人保 公告编号：临 2024-029 中国人民保险集团股份有限公司 第四届监事会第二十四次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完 整性承担个别及连带责任。 中国人民保险集团股份有限公司（"本公司"）第四届监事会第 二十四次会议（以下简称"会议"）的通知和材料于 2024 年 8 月 8 日以书面方式发送全体监事，会议于 2024 年 8 月 8 日至 8 月 28 日以 书面传签方式召开。经半数以上监事推举，会议由李慧琼监事召集。 会议的召集、召开符合《中华人民共和国公司法》等相关法律、行政 法规、部门规章和本公司章程的规定，会议合法、有效。经与会监事 审议并表决，形成以下会议决议： 一、审议通过了《关于 2024 年 A 股和 H 股半年度定期报告的议 案》 监事会认为： （一）公司 2024 年 A 股和 H 股半年度定期报告的编制和审核程 序符合法律、行政法规、部门规章和公司章程的规定； （二）公司 2024 年 A 股和 H 股半年度定期报告内容真实、准确、 特此公告。 中国人 ...